Stephanie Grebinoski is a research scientist specializing in immunology drug discovery at Takeda since September 2025. Previously, Stephanie served as a senior scientist and scientist at Seismic Therapeutic from September 2022 to August 2025. In addition, Stephanie was a graduate student researcher at the University of Pittsburgh from July 2017 to July 2022, focusing on the role of checkpoint receptors, LAG3 and NRP1, in T cell-mediated autoimmunity. Stephanie holds a Doctor of Philosophy in Microbiology and Immunology from the University of Pittsburgh and a Bachelor's of Science in Pharmaceutical Sciences from Purdue University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices